Search Results
Jan 07, 2026, 02:59 ET Euhomy Premieres Four New Portable Ice Makers at CES 2026, Redefining Ice-Making for Every Occasion
Sphere, Rock Plus Square and Ice Leopard X1 will be available by Q2, 2026. Visit Euhomy during CES at its booth in the LVCC, Central Plaza & Silver 3 — CP825 to get a first-hand look at its portable ice maker innovations.For product spec sheets and hi-res images, please find the media kit
More news about: Euhomy Technology Inc.
Dec 29, 2025, 11:00 ET CPKC to report fourth-quarter and full-year 2025 earnings results on Jan. 28, 2026
CALGARY, AB, Dec. 29, 2025 Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) will release its fourth-quarter and full-year 2025 financial and operating results after the market close on Jan. 28, 2026. CPKC
More news about: CPKC
Dec 24, 2025, 03:40 ET Safe & Secure Cities theme takes centre stage at Municipalika 2026
25–27 February 2026 at Bharat Mandapam, New Delhi. With PRAMA India and CP Plus, two of the country's most prominent surveillance and security technology leaders, confirming their participation, Municipalika 2026 is set
More news about: Fairfest Media Limited
Dec 22, 2025, 16:05 ET Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy
writhing involuntary movements), leading to severe motor impairment. DCP accounts for approximately 15% of CP cases. Currently, no therapies are approved to treat dystonia or choreoathetosis in CP.About the Phase 3 KINECT®-DCP StudyThe Phase 3, randomized, double-blind,
More news about: Neurocrine Biosciences, Inc.
Dec 22, 2025, 08:34 ET Velo Announces Integration of USD1 With World Liberty Financial to Strengthen PayFi Infrastructure Across Asia
compliance aligned and production grade financial railsAsia First, Utility Driven ExpansionWith strategic backing from CP Group, one of Asia's largest multinational conglomerates, Velo is developing a PayFi ecosystem tailored specifically for Asia's fast growing digital
More news about: Velo Labs Technology Ltd.
Dec 22, 2025, 08:15 ET Velo Announces Integration of USD1 With World Liberty Financial to Strengthen PayFi Infrastructure Across Asia
compliance aligned and production grade financial railsAsia First, Utility Driven ExpansionWith strategic backing from CP Group, one of Asia's largest multinational conglomerates, Velo is developing a PayFi ecosystem tailored specifically for Asia's fast growing digital
More news about: Velo Labs Technology Ltd.
Dec 19, 2025, 11:16 ET CPKC statement on UP-NS merger application filing
CALGARY, AB, Dec. 19, 2025 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) today released the following statement regarding the merger application filed by Union Pacific (UP) and Norfolk Southern (NS) with the Surface
More news about: CPKC
Dec 19, 2025, 09:00 ET From Black Friday to Christmas: GobiDex Turns Holiday Gifts into Long-Term Creative Companions
https://www.amazon.com/stores/GobiDex/page/11A31F84-CB2E-4DC4-A6A6-9A42BE1917C2?lp_asin=B0D3PL4CP9&ref_=cm_sw_r_ud_ast_store_NYG0M1AMB58TEKW47QB6&store_ref=bl_ast_dp_brandLogo_stoHoliday bundles, set availability, and shipping
More news about: GobiDex
Dec 18, 2025, 02:00 ET New Data from SkylineDx Demonstrates Merlin CP-GEP Test's Superior Melanoma Risk Stratification
demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior predictive accuracy for SLNB outcomes compared to 31-GEP/i31-SLNB, when evaluated under harmonized and scientifically rigorous conditionsRecent publication in early-stage melanoma shows Merlin CP-GEP Test correctly
More news about: SkylineDx
Dec 17, 2025, 18:49 ET U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® (lazertinib)
LAZCLUZE®.cp-491009v1About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation
More news about: Johnson & Johnson
Dec 17, 2025, 04:11 ET Casio India partners with NGO SHEOWS to launch 'Every Second Counts' CSR initiative to support homeless elderly
To mark the launch Casio India & SHEOWS, together held an awareness-led activation at its Connaught Place (CP) Store in Delhi.Commenting on Casio's commitment, Mr. Takuto Kimura, Managing Director, Casio India, and Mr. Akira Watanabe, Director, Casio
More news about: Casio India Co. Pvt. Ltd.
Dec 15, 2025, 16:19 ET Commercial Metals Completes Acquisition of Foley Products Company
Foley's approximately 600 employees to the CMC team," said Peter Matt, President and Chief Executive Officer. "With both the acquisitions of Foley and CP&P now closed, CMC operates one of the largest precast concrete businesses in the United States. The establishment of this platform represents a major
More news about: Commercial Metals Company
Dec 15, 2025, 10:50 ET RS improves the inherent inefficiency of compressed air systems
SMC's CP96 pneumatic actuators are designed for versatility, simplicity, reliability, repeatability, energy efficiency, and ease of integration and control
More news about: RS
Dec 15, 2025, 05:39 ET Accor dévoile ses plus belles ouvertures pour 2026
https://mma.prnewswire.com/media/2838009/CP_Accor_2026_Ouvertures_Hotels_FR.pdfLogo - https://mma.prnewswire.com/media/2836407/Accor_logo.jpg
More news about: Accor
Dec 11, 2025, 08:15 ET World's Top Riders Seek Rolex Grand Slam Glory at CHI Geneva 2025
compatriot and one of America's brightest talents, Lillie Keenan, as well as U.S. contender Kyle King, who finished a very commendable second in this year's CP 'International', presented by Rolex at Spruce Meadows.Brazilian contender Pedro Veniss heads back to Geneva – where he won the Rolex Grand Prix
More news about: Rolex Grand Slam of Show Jumping
Dec 10, 2025, 13:50 ET Velo Protocol Surges Forward with Major Partnerships and Proven Fundamentals
financial solutions, offering a cutting-edge liquidity and settlement network for secure, efficient value transfers. Backed by the Stellar Network and CP Group, our reach has expanded beyond Southeast Asia and the Pacific, now serving partners worldwide. We connect and complement the gap between traditional
More news about: Velo Labs Technology Ltd.
Dec 10, 2025, 13:17 ET Velo Protocol Surges Forward with Major Partnerships and Proven Fundamentals
financial solutions, offering a cutting-edge liquidity and settlement network for secure, efficient value transfers. Backed by the Stellar Network and CP Group, our reach has expanded beyond Southeast Asia and the Pacific, now serving partners worldwide. We connect and complement the gap between traditional
More news about: Velo Labs Technology Ltd.
Dec 10, 2025, 09:00 ET Cyberpunk 2077 Chromes Up: VITURE x CD PROJEKT RED Unleash the First-Ever Official Limited Edition XR Glasses
gaming's most iconic worlds with VITURE's award-winning XR engineering.The Collector's Edition is limited to 10,000 serialized units (CP0000 – CP9999) worldwide, with one unit numbered #2077 in tribute to the title that inspired it. Each pair features a semi-translucent, neon-infused
More news about: VITURE
Dec 08, 2025, 20:59 ET 【直擊2025 ASH】亞盛醫藥耐立克®治療TKI耐藥/不耐受CML-CP患者的註冊II期研究4年隨訪數據亮相，長期療效和安全性優勢再獲證實
耐立克®是亞盛醫藥原創1類新藥，為中國首個獲批上市的第三代BCR-ABL抑制劑。其在中國的商業化推廣由亞盛醫藥和信達生物共同負責。目前，耐立克®已在中國獲批的適應症為：治療任何TKI耐藥、並伴有T315I突變的CML-CP和加速期（-AP）的成年患者；以及治療對一代和二代TKI耐藥和/或不耐受的CML-CP成年患者，且所有獲批適應症均已被納入國家醫保藥品目錄。目前，亞盛醫藥正開展耐立克®三項全球註冊III期臨床研究，涉及CML-CP、新診斷的費城染色體陽性急性淋巴細胞白血病（Ph+ A
More news about: 亞盛醫藥
Dec 08, 2025, 20:46 ET 【直擊2025 ASH】亞盛醫藥耐立克®二線治療CML-CP臨床研究數據更新，更前線治療潛力明顯
化推廣由亞盛醫藥和信達生物共同負責。目前，耐立克®已在中國獲批的適應症為：治療任何TKI耐藥、並伴有T315I突變的CML -CP和加速期（-AP）的成年患者；以及治療對一代和二代TKI耐藥和/或不耐受的CML-CP成年患者，且所有獲批適應症均已被納入國家醫保藥品目錄。亞盛醫藥正開展耐立克®三項全球註冊III期臨床研究，涉及CML-CP、新診斷的費城染色體陽性急性淋巴細胞白血病（Ph+ ALL）、琥珀酸脫氫酶（SDH）缺陷型胃腸道間質瘤（GIST）幾大適應症。此外，亞盛醫藥已經與跨國製藥企業武田就耐立克®簽
More news about: 亞盛醫藥
Dec 08, 2025, 20:26 ET 【直擊2025 ASH】亞盛醫藥耐立克®治療初治Ph+ ALL患者註冊III期研究（POLARIS-1）數據國際首發， 最佳MRD陰性完全緩解率超60%
ALL患者中的最佳微小殘留病（MRD）陰性率和MRD陰性完全緩解（CR）率分別為66.0%和64.2%；同時顯示出良好的安全性。耐立克®是亞盛醫藥原創1類新藥，為中國首個獲批上市的第三代BCR-ABL抑制劑。其在中國的商業化推廣由亞盛醫藥和信達生物共同負責。目前，耐立克®已在中國獲批的適應症為：治療任何酪氨酸激酶抑制劑（TKI）耐藥、並伴有T315I突變的慢性髓細胞白血病（CML）慢性期（-CP）和加速期（-AP）的成年患者；以及治療對一代和二代TKI耐藥和/或不耐受的CML-CP成年患者，且所有獲批適應症均已被納入國家醫保藥品目錄。目前，亞盛醫藥正開展耐立克®三項全球註冊III期臨床研究，涉及CML-CP、新診斷的費城染色體陽性急性淋巴細胞
More news about: 亞盛醫藥
Dec 03, 2025, 10:00 ET Florida Cancer Specialists & Research Institute Contributing To Breakthroughs In Treatment of Blood Cancers & Disorders
Hematologic malignancy characteristics, clinical outcomes, and precursor statesAsciminib (ASC) in chronic myeloid leukemia in chronic Phase (CML-CP): Interim analysis (IA) efficacy and safety results of the Phase 2 ASC2ESCALATE trial in the cohort of newly diagnosed (1L) patients (pts)
More news about: Florida Cancer Specialists & Research Institute
Dec 03, 2025, 08:30 ET i4cp Releases 2026 Priorities & Predictions
here.About i4cpi4cp is the leading global research and advisory firm dedicated to helping organizations build high-performance organizations. Through its trusted human capital research, next-practices insights, and an unparalleled HR executive community, i4cp equips leaders with the
More news about: i4cp
Dec 02, 2025, 09:00 ET Next Level Aviation® obtient une augmentation de sa facilité de crédit à 80 millions de dollars auprès de la PNC Bank
Next Level Aviation-Ireland, Ltd (NLAI). Les deux facilités de crédit ont le potentiel de s'étendre au fil du temps en fonction de la croissance des CP et des INL.
More news about: Next Level Aviation
Dec 01, 2025, 16:15 ET Commercial Metals Completes Acquisition of Concrete Pipe & Precast, LLC
has successfully completed the acquisition of Concrete Pipe & Precast, LLC ("CP&P") from Eagle Corporation and ECPP, LLC for a cash purchase price of $675 million, subject to customary adjustments. CP&P is a leading supplier of precast concrete and pipe products to the Mid-Atlantic
More news about: Commercial Metals Company